Friday, October 21, 2011

Impel NeuroPharma Raises $500K In Series B

Seattle-based Impel Neuropharma, a developer of biomedical devices, has raised $500,000 in a Series B, angel funding round, the firm said Thursday. Names of those angel investors were not detailed. Impel Neuropharma is developing a medical device, which is aimed at drug delivery and enabling drugs to bypass the blood-brain barrier via an intranasal drug delivery device. The firm is headed by Michael Hite. More information »